Report (2017) of the International Registry on Hand and Composite Tissue Allotransplantation (IRHCTT)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lanzetta M, Petruzzo P, Margreiter R, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation. 2005;79(9):1210–4.
Petruzzo P, Dubernard JM. The International Registry on Hand and Composite Tissue Allotransplantation. Clin Transpl. 2011;27(4):247–53.
Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8(7):1396–400.
Lanzetta M, Petruzzo P. A comprehensive functional score system in hand transplantation. In: Lanzetta M, Dubernard JM, editors. Hand transplantation: Springer-Verlag: Italia Milano; 2007.
Gummesson C, Atroshi I, Ekdahl C. The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord. 2003;16(4):11.
• Howsare M, Jones CM, Ramirez AM. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right? Curr Opin Organ Transplant. 2017;22(5):463–9. This reviews offers a detailed report of the immunosuppressive maintenance therapy for VCA and an interesting discussion on the determination of the right amount of immunosuppression in VCA
• Hammond SP. Infections in composite tissue allograft recipients. Infect Dis Clin N Am. 2013;27(2):379–93. This review summarizes infectious complications in recipients of facial and hand allotransplantation and reports infection prophylaxis practice
•• Broyles JM, Alrakan M, Ensor CR, Khalifian S, Kotton CN, Avery RK, et al. Characterization, prophylaxis, and treatment of infectious complications in craniomaxillofacial and upper extremity allotransplantation: a multicenter perspective. Plast Reconstr Surg. 2014;133(4):543e–51e. In this article, the authors review the infectious risks to patients after VCAs. They underline prophylaxis and treatment of infections in these particular recipients of reconstructive transplantation